comparemela.com

Latest Breaking News On - American society of hematology annual meeting exposition - Page 1 : comparemela.com

BTK Inhibitor Combinations Move to Forefront of CLL Investigations, Conversations

Mazyar Shadman, MD, MPH, details the efficacy of BTK inhibitors in the frontline treatment of CLL as well as safety considerations in the relapsed/refractory setting.

United-states
Washington
North-carolina
Switzerland
Lugano
Ticino
University-of-washington
Seattle
American
Alan-skarbnik
Mazyar-shadman
American-society-of-hematology-annual-meeting-exposition

MAIC Methodology Matters: Comparing BRUKINSA vs Acalabrutinib in R/R CLL

MAIC Methodology Matters: Comparing BRUKINSA vs Acalabrutinib in R/R CLL
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

United-states
Florida
California
Miami
San-diego
American
Mehrdad-mobasher
American-society-of-hematology-annual-meeting-exposition
American-society-of-hematology
International-congress-on-hematologic-malignancies
Chief-medical-officer
Annual-international-congress

Emavusertib Progresses to Phase 2 Study in AML and MDS

The TakeAim Leukemia trial aims to add emavusertib to the treatment paradigm of acute myeloid leukemia and high-risk myelodysplastic syndrome.

California
United-states
Dana-farber-cancer-institute
Massachusetts
San-diego
Boston
American
Erics-winer
Alices-mims
Curis-inc
Division-of-hematology

Mitigating Financial Toxicity in Cancer Care Requires Policy Reform, Rethinking Benefit Design

From the panel discussion, "The Burden They Carry," a discussion of the impact of financial toxicity over the duration of the cancer journey.

Minnesota
United-states
Tennessee
New-jersey
Vanderbilt-university
Cinnaminson
American
Anita-kumar
Stacieb-dusetzina
Rajini-katipamula-malisetti
Brian-osullivan
Vanderbilt-university-medical-center

Data From 2023 ASH Annual Meeting Provide Positive Updates in Multiple Myeloma

Experts discuss treatment in newly diagnosed multiple myeloma and the role of CAR T-cell therapies and bispecifics in relapsed/refractory disease.

California
United-states
Illinois
San-diego
Chicago
American
Caitlin-costello
Krinak-patel
American-society-of-clinical-oncology-annual-meeting
Onclive-peer-exchange
American-society-of-hematology-annual-meeting-exposition
American-society

vimarsana © 2020. All Rights Reserved.